Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3323 ARTÍCULOS , VIENDO DEL 2971 AL 2985

Deep brain stimulation can suppress pathological synchronisation in parkinsonian patients

Eusebio A, Thevathasan W, Doyle Gaynor L, Pogosyan A, Bye E, Foltynie T, Zrinzo L, Ashkan K, Aziz T, Brown P.

J Neurol Neurosurg Psychiatry. 2011 May;82(5):569-73. doi: 10.1136/jnnp.2010.217489. Epub 2010 Oct 9.

Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues

Bronstein JM, Tagliati M, Alterman RL, Lozano AM, Volkmann J, Stefani A, Horak FB, Okun MS, Foote KD, Krack P, Pahwa R, Henderson JM, Hariz MI, Bakay RA, Rezai A, Marks WJ Jr, Moro E, Vitek JL, Weaver FM, Gross RE, DeLong MR.

Arch Neurol. 2011 Feb;68(2):165. doi: 10.1001/archneurol.2010.260. Epub 2010 Oct 11.

Is there a delayed gastric emptying of patients with early-stage, untreated Parkinson's disease? An analysis using the 13C-acetate breath test

Tanaka Y, Kato T, Nishida H, Yamada M, Koumura A, Sakurai T, Hayashi Y, Kimura A, Hozumi I, Araki H, Murase M, Nagaki M, Moriwaki H, Inuzuka T.

J Neurol. 2011 Mar;258(3):421-6. doi: 10.1007/s00415-010-5769-z. Epub 2010 Oct 12.

Mitochondrial dementia: a sporadic case of progressive cognitive and behavioral decline with hearing loss due to the rare m.3291T>C MELAS mutation

Salsano E, Giovagnoli AR, Morandi L, Maccagnano C, Lamantea E, Marchesi C, Zeviani M, Pareyson D.

J Neurol Sci. 2011 Jan 15;300(1-2):165-8. doi: 10.1016/j.jns.2010.09.022. Epub 2010 Oct 12.

Inflammation and gliosis in neurological diseases--clinical implications

Członkowska A, Kurkowska-Jastrzębska I.

J Neuroimmunol. 2011 Feb;231(1-2):78-85. doi: 10.1016/j.jneuroim.2010.09.020. Epub 2010 Oct 12.

Risk factors for bullous pemphigoid in the elderly: a prospective case-control study

Bastuji-Garin S, Joly P, Lemordant P, Sparsa A, Bedane C, Delaporte E, Roujeau JC, Bernard P, Guillaume JC, Ingen-Housz-Oro S, Maillard H, Pauwels C, Picard-Dahan C, Dutronc Y, Richard MA; French Study Group for Bullous Diseases.

J Invest Dermatol. 2011 Mar;131(3):637-43. doi: 10.1038/jid.2010.301. Epub 2010 Oct 14.

Oral high-calorie, low-protein supplements in a Parkinson's disease patient: a case report

Barichella M, Madio C, Cassani E, Magris C, Pezzoli G.

Mov Disord. 2011 Feb 1;26(2):354-5. doi: 10.1002/mds.23373. Epub 2010 Oct 13.

Indirubin-3'-oxime inhibits inflammatory activation of rat brain microglia

Jung HJ, Nam KN, Son MS, Kang H, Hong JW, Kim JW, Lee EH.

Neurosci Lett. 2011 Jan 7;487(2):139-43. doi: 10.1016/j.neulet.2010.10.009. Epub 2010 Oct 12.

Granulocyte-colony stimulating factor (G-CSF) enhances recovery in mouse model of Parkinson's disease

Song S, Sava V, Rowe A, Li K, Cao C, Mori T, Sanchez-Ramos J.

Neurosci Lett. 2011 Jan 7;487(2):153-7. doi: 10.1016/j.neulet.2010.10.012. Epub 2010 Oct 14.

Striatal Aβ peptide deposition mirrors dementia and differentiates DLB and PDD from other parkinsonian syndromes

Kalaitzakis ME, Walls AJ, Pearce RK, Gentleman SM.

Neurobiol Dis. 2011 Feb;41(2):377-84. doi: 10.1016/j.nbd.2010.10.005. Epub 2010 Oct 14.

High cerebrospinal tau levels are associated with the rs242557 tau gene variant and low cerebrospinal β-amyloid in Parkinson disease

Compta Y, Ezquerra M, Muñoz E, Tolosa E, Valldeoriola F, Rios J, Cámara A, Fernández M, Buongiorno MT, Marti MJ.

Neurosci Lett. 2011 Jan 7;487(2):169-73. doi: 10.1016/j.neulet.2010.10.015. Epub 2010 Oct 15.

LINGO1 rs9652490 variant in Parkinson disease patients

Guo Y, Jankovic J, Song Z, Yang H, Zheng W, Le W, Tang X, Deng X, Yang Y, Deng S, Luo Z, Deng H.

Neurosci Lett. 2011 Jan 7;487(2):174-6. doi: 10.1016/j.neulet.2010.10.016. Epub 2010 Oct 15.

Measurement of patient-centered outcomes in Parkinson's disease: what do patients really want from their treatment?

Nisenzon AN, Robinson ME, Bowers D, Banou E, Malaty I, Okun MS.

Parkinsonism Relat Disord. 2011 Feb;17(2):89-94. doi: 10.1016/j.parkreldis.2010.09.005. Epub 2010 Oct 16.

Presynaptic control of serotonin on striatal dopamine function

Navailles S, De Deurwaerdère P.

Psychopharmacology (Berl). 2011 Feb;213(2-3):213-42. doi: 10.1007/s00213-010-2029-y. Epub 2010 Oct 16.

Treatment for prolactinomas and hyperprolactinaemia: a lifetime approach

Mann WA.

Eur J Clin Invest. 2011 Mar;41(3):334-42. doi: 10.1111/j.1365-2362.2010.02399.x. Epub 2010 Oct 18.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias